UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

European urology, 2015-07, Vol.68 (1), p.139-146

2015

Volltextzugriff (PDF)

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

Prostate cancer and prostatic diseases, 2018-04, Vol.21 (1), p.57-63

2018

Volltextzugriff (PDF)

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential

European urology, 2018-08, Vol.74 (2), p.204-210

2018

Volltextzugriff (PDF)

Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection

Journal of magnetic resonance imaging, 2024-08, Vol.60 (2), p.458-468

2024

Volltextzugriff (PDF)

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications

European journal of cancer (1990), 2015-04, Vol.51 (6), p.725-733

2015

Volltextzugriff (PDF)

Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

Value in health, 2021-12, Vol.24 (12), p.1763-1772

2021

Volltextzugriff (PDF)

Towards Next-generation Urine-based Prostate Cancer Risk Stratification

European urology, 2018-12, Vol.74 (6), p.739-740

2018

Volltextzugriff (PDF)

Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions

JNCI : Journal of the National Cancer Institute, 2016-12, Vol.108 (12), p.djw165

2016

Volltextzugriff (PDF)

Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003–2011

European urology, 2013-03, Vol.63 (3), p.419-425

2013

Volltextzugriff (PDF)

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

JAMA oncology, 2022-07, Vol.8 (7), p.1019

2022

Volltextzugriff (PDF)

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

Journal of clinical pathology, 2020-10, Vol.73 (10), p.630-635

2020

Volltextzugriff (PDF)

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)

JNCI : Journal of the National Cancer Institute, 2021-05, Vol.113 (5), p.632-640

2021

Volltextzugriff (PDF)

Association between PSA density and prostate cancer in men without significant MRI lesions

BJU international, 2020-06, Vol.125 (6), p.763-764

2020

Volltextzugriff (PDF)

Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722–8

European urology, 2019-04, Vol.75 (4), p.e104-e105

2019

Volltextzugriff (PDF)

Reducing private car demand, fact or fiction? A study mapping changes in accessibility to grocery stores in Norway

European transport research review, 2021, Vol.13 (1), p.39-39, Article 39

2021

Volltextzugriff (PDF)

A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1–3 ng/ml

European urology, 2014-06, Vol.65 (6), p.1184-1190

2014

Volltextzugriff (PDF)

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

Prostate cancer and prostatic diseases, 2019-03, Vol.22 (1), p.137-142

2019

Volltextzugriff (PDF)

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study

JAMA oncology, 2023-01, Vol.9 (1), p.88

2023

Volltextzugriff (PDF)

Reply to Ola Bratt and Anna Öfverholm's Letter to the Editor re: Peter Ström, Tobias Nordström, Henrik Grönberg, Martin Eklund. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.12.028

European urology, 2018-07, Vol.74 (1), p.e10-e11

2018

Volltextzugriff (PDF)

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies

World journal of urology, 2021-04, Vol.39 (4), p.1153-1159

2021

Volltextzugriff (PDF)

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139–46

European urology, 2018-08, Vol.74 (2), p.e35-e36

2018

Volltextzugriff (PDF)

External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort

European urology focus, 2023-05, Vol.9 (3), p.455-462

2023

Volltextzugriff (PDF)

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer

Nature communications, 2017-01, Vol.8 (1), p.14248-14248, Article 14248

2017

Volltextzugriff (PDF)

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

The lancet oncology, 2015-12, Vol.16 (16), p.1667-1676

2015

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(96)
Mit Volltextzugriff
(88)

Publikationsform

Artikel
(96)

Sprache

Englisch
(96)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

Prostate-specific antigen (PSA) density in the diagnostic algorithm of prostate cancer

The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential

Prostate Age Gap: An MRI Surrogate Marker of Aging for Prostate Cancer Detection

The risk of prostate cancer for men on aspirin, statin or antidiabetic medications

Cost-Effectiveness of Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

Towards Next-generation Urine-based Prostate Cancer Risk Stratification

Repeat Prostate-Specific Antigen Tests Before Prostate Biopsy Decisions

Prostate-specific Antigen (PSA) Testing Is Prevalent and Increasing in Stockholm County, Sweden, Despite No Recommendations for PSA Screening: Results from a Population-based Study, 2003–2011

Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality

Prognostic value of perineural invasion in prostate needle biopsies: a population-based study of patients treated by radical prostatectomy

Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS)

Association between PSA density and prostate cancer in men without significant MRI lesions

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis

Reply to Erik Rud, Peter Lauritzen, and Eduard Baco's Letter to the Editor re: Henrik Grönberg, Martin Eklund, Wolfgang Picker, et al. Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging. Eur Urol 2018;74:722–8

Reducing private car demand, fact or fiction? A study mapping changes in accessibility to grocery stores in Norway

A Genetic Score Can Identify Men at High Risk for Prostate Cancer Among Men With Prostate-Specific Antigen of 1–3 ng/ml

The Stockholm3 blood-test predicts clinically-significant cancer on biopsy: independent validation in a multi-center community cohort

Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study

Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies

Re: Tobias Nordström, Andrew Vickers, Melissa Assel, Hans Lilja, Henrik Grönberg, Martin Eklund. Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer. Eur Urol 2015;68:139–46

External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort

Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

Aktive Filter

Suchergebnisse filtern